Respiratory disorders, especially non-communicable, chronic inflammatory diseases, are
amongst the leading causes of mortality and morbidity worldwide. Respiratory diseases …

COVID-19 caused by the SARS-CoV-2 virus is a fast emerging disease with deadly
consequences. The pulmonary system and lungs in particular are most prone to damage …

Aim: In the present study boswellic acids-loaded chitosan nanoparticles were synthesized
using ionic gelation technique. The influence of independent variables were studied and …

Cancer continues to be one of the most challenging diseases to be treated and is one of the
leading causes of deaths around the globe. Cancers account for 13% of all deaths each …

The present study aimed to formulate anti-tubercular drugs (Rifampicin, Isoniazid and
Pyrazinamide) loaded solid lipid nanoparticles (ATDs-SLNs) using microemulsion technique …

Chronic airway inflammatory diseases are characterized by persistent proinflammatory
responses in the respiratory tract. Although, several treatment strategies are currently …

Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation with
persistent respiratory symptoms. Current therapeutics for COPD are largely borrowed from …

Our study is aimed at evaluating the effects of pretreatment with Poly (lactic‐co‐glycolic) acid
nanoparticle loaded with resveratrol (RSV PLGA NPs) compared to conventional resveratrol …

Highlights•RNAi is a promising antiviral development strategy.•Pathways include classic
RNAi (mRNA target) and novel RNAi (promoter target).•Most RNAi therapeutics act via …

Outbreaks of influenza infections in the past have severely impacted global health and
socioeconomic growth. Antivirals and vaccines are remarkable medical innovations that …